Effects and Safety of Henagliflozin on Cardiac Structure in Patients with Heart Failure with Preserved Ejection Fraction on Dialysis

医学 腹膜透析 心脏病学 内科学 射血分数 安慰剂 透析 心力衰竭 血液透析 置信区间 利钠肽 射血分数保留的心力衰竭 随机对照试验 冲程容积 血管内容积状态 子群分析 脑利钠肽 临床试验 心输出量 体质指数 心脏指数 血压 心脏病 前瞻性队列研究
作者
Hao Yan,Wei Wang,Wangshu Wu,Ying Li,Yinghui Qi,Yijun Zhou,Weiming Zhang,Shang Liu,Huihua Pang,Yan Fang,Zhenyuan Li,Zhiqing Qiao,Renhua Lu,Meng Jiang,Wei Fang,Jun Pu,Leyi Gu,on behalf of the HELD-HF study investigators
出处
期刊:Clinical Journal of The American Society of Nephrology [Lippincott Williams & Wilkins]
被引量:2
标识
DOI:10.2215/cjn.0000001201
摘要

KEY POINTS: This trial evaluated the effects of henagliflozin on cardiac structure and its safety in patients with heart failure with preserved ejection fraction on dialysis. At week 24, henagliflozin achieved a statistically significant reduction in left ventricular mass index versus placebo (-5.27 g/m 2 ; 95% confidence interval, -10.02 to -0.53 g/m 2 ). Henagliflozin was tolerable in the peritoneal dialysis and hemodialysis settings. BACKGROUND: Few effective drug treatments exist for patients with heart failure with preserved ejection fraction (HFpEF) on dialysis. The aim of this study was to evaluate the effects of henagliflozin, a sodium-glucose cotransporter 2 inhibitor, on cardiac structure and its safety in such population. METHODS: In this multicenter, randomized, double-blind, placebo-controlled trial, patients with HFpEF on dialysis were randomly assigned (1:1) to receive henagliflozin or placebo for 24 weeks. All enrolled participants received conventional therapy. The primary outcome was change in left ventricular mass index (LVMI) from baseline to week 24. The secondary outcomes were changes in the left atrial volume index, E/e', e', and N -terminal pro-brain natriuretic peptide and safety. Efficacy was assessed in the intention-to-treat population. Safety was assessed in the as-treated population. Analysis of covariance was used to assess treatment effects. RESULTS: A total of 112 participants were randomly assigned to the henagliflozin group ( n =56) and placebo group ( n =56). Of these, 60 participants were on hemodialysis and 52 were on peritoneal dialysis. From baseline to week 24, henagliflozin resulted in a greater reduction in least-squares mean (±SEM) change in LVMI than placebo (-3.27±1.71 g/m 2 versus 2.01±1.69 g/m 2 ), with a between-group difference of -5.27 g/m 2 (95% confidence interval [CI], -10.02 to -0.53 g/m 2 ; P = 0.03). In the prespecified subgroup by dialysis modality, the between-group difference in LVMI change from baseline to week 24 was -6.86 g/m 2 (95% CI, -14.02 to 0.29 g/m 2 ) among participants on peritoneal dialysis and -3.91 g/m 2 (95% CI, -10.45 to 2.63 g/m 2 ) among participants on hemodialysis. No between-group differences in secondary outcomes were observed. The incidence of adverse events was similar between the henagliflozin and placebo groups (36% versus 34%). CONCLUSIONS: Henagliflozin was associated with a greater reduction in LVMI at week 24 compared with placebo and was tolerable in patients with HFpEF on dialysis. Larger studies are needed to confirm the LVMI-lowering effect of henagliflozin. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: ChiCTR2300073169.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
雅士白农学家完成签到,获得积分10
刚刚
程艾影完成签到,获得积分20
刚刚
夸克酱发布了新的文献求助10
1秒前
西米完成签到,获得积分10
1秒前
1秒前
ak发布了新的文献求助10
1秒前
aabbc发布了新的文献求助10
1秒前
1秒前
2秒前
2秒前
2秒前
2秒前
ZJ发布了新的文献求助10
3秒前
3秒前
噜噜噜的应助被MJC采纳,获得10
3秒前
syvshc的应助被MJC采纳,获得10
4秒前
4秒前
syvshc的应助被MJC采纳,获得10
4秒前
王木木完成签到 ,获得积分10
4秒前
深情安青的应助被伯远ls采纳,获得10
4秒前
4秒前
4秒前
小汤圆完成签到,获得积分20
4秒前
4秒前
yumuhai发布了新的文献求助10
5秒前
yumuhai发布了新的文献求助10
5秒前
一根薯条儿完成签到,获得积分10
5秒前
yumuhai发布了新的文献求助10
5秒前
yumuhai发布了新的文献求助10
5秒前
yumuhai发布了新的文献求助10
5秒前
yumuhai发布了新的文献求助10
5秒前
yumuhai发布了新的文献求助10
5秒前
yumuhai发布了新的文献求助10
5秒前
yumuhai发布了新的文献求助10
5秒前
6秒前
星辰大海的应助被科研采纳,获得10
6秒前
6秒前
zyq关注了科研通微信公众号
7秒前
YHT发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182706
求助须知:如何正确求助?哪些是违规求助? 9572086
关于积分的说明 21822405
捐赠科研通 7779207
什么是DOI,文献DOI怎么找? 3433702
关于科研通互助平台的介绍 2557891
邀请新用户注册赠送积分活动 2479787